Norepinephrine transporter polymorphisms in Tourette syndrome with and without attention deficit hyperactivity disorder: no evidence for significant association.

Norepinephrine transporter polymorphisms in Tourette syndrome with and without attention deficit hyperactivity disorder: no evidence for significant association. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Norepinephrine transporter polymorphisms in Tourette syndrome with and without attention deficit hyperactivity disorder: no evidence for significant association. Abstract Text:

Christopher A Rippel,Andrew J Kobets,Dustin Y Yoon,Phillip N Williams,Yin Yao Shugart,Dana D Bridges,David J Vandenbergh,Harvey S Singer,

Noradrenergic abnormalities have been proposed in the pathophysiology of Tourette syndrome and attention-deficit hyperactivity disorder. Patients with Tourette syndrome with (n=115) and without (n=110) attention-deficit hyperactivity disorder were evaluated for association with two single nucleotide polymorphisms of the norepinephrine transporter gene (SLC6A2); a T-182C single nucleotide polymorphism located in the 5' flanking promoter region and a silent mutation (G1287A) occurring in exon 9. A polymerase chain reaction restriction enzyme assay was developed for the T-182C single nucleotide polymorphism based on a prior sequencing methodology. In this case-control study, no association was identified between either polymorphism and Tourette syndrome or attention-deficit hyperactivity disorder. In a small subset, these NET polymorphisms did not predict therapeutic response to the noradrenergic transporter inhibitor atomoxetine. Further research with additional NET polymorphisms and larger sample sizes are indicated in the pursuit of biomarkers for therapeutic responders.

Norepinephrine transporter polymorphisms in Tourette syndrome with and without attention deficit hyperactivity disorder: no evidence for significant association. Publishing Authors By Initials

CA Rippel,AJ Kobets,DY Yoon,PN Williams,YY Shugart,DD Bridges,DJ Vandenbergh,HS Singer,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Norepinephrine transporter polymorphisms in Tourette syndrome with and without attention deficit hyperactivity disorder: no evidence for significant association. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Psychiatric genetics

VOLUME: 16

Page Numbers: 179-80

Journal Abbreviation:

ISSN: 0955-8829

DAY: 3

MONTH: Oct

YEAR: 2006

Norepinephrine transporter polymorphisms in Tourette syndrome with and without attention deficit hyperactivity disorder: no evidence for significant association. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9106748

Norepinephrine transporter polymorphisms in Tourette syndrome with and without attention deficit hyperactivity disorder: no evidence for significant association. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Norepinephrine transporter polymorphisms in Tourette syndrome with and without attention deficit hyperactivity disorder: no evidence for significant association. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Norepinephrine transporter polymorphisms in Tourette syndrome with and without attention deficit hyperactivity disorder: no evidence for significant association.

AFFILIATION: Department of Neurology, Johns Hopkins University School of Medicine, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Psychiatr Genet

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Norepinephrine transporter polymorphisms in Tourette syndrome with and without attention deficit hyperactivity disorder: no evidence for significant association Related Publications

• A longitudinal case study of a child with mosaic trisomy 22: language, cognitive, behavioral, physical, and dental outcomes.
• A progressive, fatal dystonia-Parkinsonism syndrome in a patient with primary immunodeficiency receiving chronic IVIG therapy.
• A recipe for randomness.
• Aggressive drug marketing tactics trigger backlash.
• Bupropion for smokers hospitalized with acute cardiovascular disease.
• Chemotherapy is associated with improved survival in adult patients with primary extremity synovial sarcoma.
• Combinations of biomarkers predictive of later life mortality.
• Constitutive turnover of cyclin E by Cul3 maintains quiescence.
• Detection and Classification of Movements in Bed using Load Cells.
• Education correction using years in school or reading grade-level equivalent? Comparing the accuracy of two methods in diagnosing HIV-associated neurocognitive impairment.
• Frontal dopaminergic abnormality in Tourette syndrome: a postmortem analysis.
• In vivo dynamics of RNA polymerase II transcription.
• Laryngeal dystonia as a presenting symptom of young-onset Parkinson's disease.
• Mast cell-mediated changes in smooth muscle contractility during mouse giardiasis.
• Metastasis to the submandibular gland in head and neck carcinomas.
• Norepinephrine transporter polymorphisms in Tourette syndrome with and without attention deficit hyperactivity disorder: no evidence for significant association.
• Postdischarge treatment costs following closure of a state geropsychiatric ward: comparison of 2 levels of community care.
• Prenatal cocaine and tobacco effects on children's language trajectories.
• Role of the brain-gut axis in alcohol-related gastrointestinal diseases--what can we learn from new animal models?
• Selective effects of cyclosporin A on colony-forming lymphoid and myeloid cells in man.
• Sleep and sleep disturbance: from genes to dreams.
• The Cullin3 ubiquitin ligase functions as a Nedd8-bound heterodimer.
• The aging experience of well elderly women: initial results.
• The headache doctor: the dog ate my pills and other tales of woe.
• The validity of the 2004 U.S. News & World Report's rankings of schools of social work: a response.
• Tic disorders: neural circuits, neurochemistry, and neuroimmunology.
• Tumour necrosis factor alpha contributes to protection against Giardia lamblia infection in mice.
• Within-trial contrast: pigeons prefer conditioned reinforcers that follow a relatively more rather than a less aversive event.
• [Ectopic prostatic tissue in the uterine cervix]
• [Meningothelial meningioma in a mature cystic teratoma of the ovary]